Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival

Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer

(2015) C-H Koh et al.   BRITISH JOURNAL OF CANCER

C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study

(2014) Laure Dossus et al.   CANCER CAUSES & CONTROL

A Prospective Follow-up Study of the Relationship between C-Reactive Protein and Human Cancer Risk in the Chinese Kailuan Female Cohort

(2014) G. Wang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

(2014) Ahmet Dirican et al.   International Journal of Clinical Oncology

Prognostic Influence of Pre-Operative C-Reactive Protein in Node-Negative Breast Cancer Patients

(2014) Isabel Sicking et al.   PLoS One

Weight, inflammation, cancer-related symptoms and health-related quality of life among breast cancer survivors

(2013) Ikuyo Imayama et al.   BREAST CANCER RESEARCH AND TREATMENT

Post-surgical highly sensitive C-reactive protein and prognosis in early-stage breast cancer

(2013) Ariadna Tibau et al.   BREAST CANCER RESEARCH AND TREATMENT

Distribution and determinants of C-reactive protein in the older adult population: European Prospective Investigation into Cancer-Norfolk study

(2013) Sara Ahmadi-Abhari et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Obesity/Weight Gain and Breast Cancer Risk: Findings From the Japan Collaborative Cohort Study for the Evaluation of Cancer Risk

(2013) Sadao Suzuki et al.   JOURNAL OF EPIDEMIOLOGY

The sixth survey of the Tromsø Study (Tromsø 6) in 2007–08: Collaborative research in the interface between clinical medicine and epidemiology: Study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey

(2013) Anne Elise Eggen et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Inflammatory Biomarkers as Risk Factors for Future Atrial Fibrillation. An Eleven-Year Follow-Up of 6315 Men and Women: The Tromsø Study

(2012) Audhild Nyrnes et al.   Gender Medicine

The growing challenge of obesity and cancer: an inflammatory issue

(2011) Alison E. Harvey et al.   Annals of the New York Academy of Sciences

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Cohort profile: The Tromso Study

(2011) B. K. Jacobsen et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients

(2009) Brandon L. Pierce et al.   JOURNAL OF CLINICAL ONCOLOGY

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Immune infiltration in human tumors: a prognostic factor that should not be ignored

(2009) F Pagès et al.   ONCOGENE

Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis

(2008) Katriina Heikkilä et al.   CANCER CAUSES & CONTROL

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

(2008) Inger Kristin Larsen et al.   EUROPEAN JOURNAL OF CANCER

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE